Biotest AG
XMUN:BIO
Biotest AG
XMUN:BIO
Price:
43
EUR
Market Closed
Market Cap:
€1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biotest AG
XMUN:BIO
|
DE |
|
D
|
Dynavax Technologies Corp
F:DYF1
|
US |
|
S
|
Sembcorp Industries Ltd
XMUN:SBOA
|
SG |
|
C
|
Cal-Comp Electronics Thailand PCL
SET:CCET
|
TH |
|
I
|
IONOS Group SE
XBER:IOS
|
DE |
|
LendLease Group
ASX:LLC
|
AU |
|
S
|
Software AG
XMUN:SOW
|
DE |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
|
B
|
Bavarian Nordic A/S
XMUN:BV3
|
DK |
|
Itesoft SA
PAR:ITE
|
FR |
|
Medx Health Corp
XTSX:MDX
|
CA |
|
Stevva Corp
OTC:STVA
|
GR |
|
O
|
Optical Cable Corp
F:OCC
|
US |
|
O
|
Orion Oyj
F:OFK
|
FI |
|
Blue Bird Corp
F:4RB
|
US |
|
A
|
Altea Green Power SpA
F:Q51
|
IT |
|
N
|
Novabase SGPS SA
XMUN:NVQ
|
PT |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIO's stock price target?
Not Available
BIO does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%
-1%
Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.
What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%
25%
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.
